Member access

4-Traders Homepage  >  Shares  >  Swiss Exchange  >  Addex Therapeutics Ltd    ADXN   CH0029850754

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancials 
Quotes 5-day view   End-of-day quote. End-of-day quote Swiss Exchange
01/26/2015 01/27/2015 01/28/2015 01/29/2015 01/30/2015 Date
3.36(c) 3.44(c) 3.3(c) 3.28(c) 3.2(c) Last
158 538 108 091 77 884 51 085 61 096 Volume
-5.62% +2.38% -4.07% -0.61% -2.44% Change
More quotes
Company
Addex Therapeutics Ltd. engages in the discovery and development of oral small molecule drugs.The company uses its proprietary discovery platform to address receptors and other proteins that are undruggable for conventional drug discovery methods, including G-protein coupled receptors, receptor... 
More about the company
Chart ADDEX THERAPEUTICS LTD
Duration : Period :
Addex Therapeutics Ltd Technical Analysis Chart | ADXN | CH0029850754 | 4-Traders
Full-screen chart
Latest news on ADDEX THERAPEUTICS LTD
01/20 ADDEX THERAPEUTICS : DMRF partner to explore therapeutic use of dipraglurant in ..
01/19 ADDEX THERAPEUTICS : and Dystonia Medical Research Foundation Announce Partnersh..
01/09 ADDEX THERAPEUTICS : Completes 2014 with Strong Cash Position and Provides 2015 ..
01/07 ADDEX THERAPEUTICS : and NIAAA Enter Collaboration to Evaluate ADX71441 in Alcoh..
2014 ADDEX THERAPEUTICS : Amends mGlu2PAM Collaboration Agreement and Receives USD757..
2014 ADDEX THERAPEUTICS : and the Charcot-Marie-Tooth Association enter collaboration..
2014 ADDEX THERAPEUTICS : and the Charcot-Marie-Tooth Association enter collaboration..
2014 ADDEX THERAPEUTICS : Reports First Half 2014 Financial Results
More news
Sector news Biotechnology & Medical Research - NEC
06:14a PHARMACYCLICS : Johnson & Johnson: U.S. FDA Approves IMBRUVICA (ibrutinib) for t..
01/29DJValeant to Buy Prostate-Cancer Drug From Dendreon
01/29DJValeant in Deal to Buy Prostate-Cancer Drug Provenge From Dendreon
Plus d'actualités du secteur Biotechnology & Medical Research - NEC


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF